Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $408.66 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sandoz Inc. | $188.42 | 2 | $0 (2017) |
| PFIZER INC. | $111.37 | 1 | $0 (2019) |
| ViiV Healthcare Company | $69.44 | 4 | $0 (2019) |
| Gilead Sciences, Inc. | $23.60 | 1 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $15.83 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $162.63 | 4 | PFIZER INC. ($111.37) |
| 2018 | $57.61 | 3 | Gilead Sciences, Inc. ($23.60) |
| 2017 | $188.42 | 2 | Sandoz Inc. ($188.42) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/21/2019 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: HIV | ||||||
| 06/20/2019 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: HIV | ||||||
| 05/14/2019 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $111.37 | General |
| Category: DERMATOLOGY | ||||||
| 03/08/2019 | ViiV Healthcare Company | JULUCA (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: HIV | ||||||
| 11/26/2018 | ViiV Healthcare Company | TRIUMEQ (Drug), JULUCA | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: HIV | ||||||
| 04/11/2018 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/14/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.60 | General |
| 04/04/2017 | Sandoz Inc. | KERYDIN (Drug) | Food and Beverage | In-kind items and services | $99.15 | General |
| Category: DERMATOLOGY | ||||||
| 01/04/2017 | Sandoz Inc. | KERYDIN (Drug) | Food and Beverage | In-kind items and services | $89.27 | General |
| Category: DERMATOLOGY | ||||||
About Dr. Marcus Conant, MD
Dr. Marcus Conant, MD is a Medical Specialty healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013927128.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marcus Conant, MD has received a total of $408.66 in payments from pharmaceutical and medical device companies, with $162.63 received in 2019. These payments were reported across 9 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($408.66).
Practice Information
- Specialty Medical Specialty
- Location San Francisco, CA
- Active Since 08/09/2006
- Last Updated 07/08/2007
- Taxonomy Code 261QM2500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1013927128
Products in Payments
- KERYDIN (Drug) $188.42
- EUCRISA (Drug) $111.37
- DOVATO (Drug) $31.93
- JULUCA (Drug) $19.33
- TRIUMEQ (Drug) $18.18
- ISENTRESS (Drug) $15.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.